Full Breakdown
Personalized Noninvasive Brain Stimulation Targets Hippocampal Dysfunction
4/4/2026, 7:43:17 PM
Breakthrough in Neuromodulation Techniques
Researchers at the University of Iowa have made significant strides in noninvasive brain stimulation, specifically targeting the hippocampus, a deep brain region crucial for memory and emotion. This study addresses the challenges of treating conditions linked to hippocampal dysfunction, such as Alzheimer’s disease, depression, anxiety, and post-traumatic stress disorder (PTSD). The findings suggest a novel approach that could lead to safer and more effective treatments without the need for invasive procedures or broadly acting medications.
Study Overview and Methodology
The research involved eight neurosurgical patients who had electrodes implanted in their hippocampus, allowing for a unique combination of noninvasive transcranial magnetic stimulation (TMS) and intracranial electroencephalography (iEEG) to measure immediate activity changes. The team, led by senior author Jing Jiang, PhD, tailored the stimulation sites based on each patient's individual brain connectivity, identified through resting-state functional magnetic resonance imaging (fMRI). This personalization resulted in significant activity changes in the hippocampus when the stimulation was applied to the individualized cortical sites. In contrast, non-personalized stimulation did not yield robust responses.
Implications for Treatment
The study's results indicate that a connectivity-informed strategy enhances the effectiveness of neuromodulation. By personalizing stimulation sites, researchers believe they can improve treatment outcomes and potentially predict individual responses to therapy. Jiang emphasized the importance of this approach, stating, “This connectivity-informed strategy provides more precise targeting and modulation, which improves the effectiveness of stimulation effect, and may even help predict individual responses.”
Funding and Collaborators
The research was supported by grants from the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the Brain and Behavior Research Foundation, Magnus Medical, Inc., and the Roy J. Carver Charitable Trust. The study team included first author Zhuoran Li and other University of Iowa researchers, as well as Amit Etkin from Alto Neuroscience.
Criticism & Opposition
While the study presents promising findings, some experts in the field may raise questions about the scalability of personalized neuromodulation techniques in broader clinical settings. The reliance on advanced imaging and individualized assessments could pose challenges in routine practice, where resources may be limited.
What's Next
The research team plans to further investigate the potential of this personalized neuromodulation approach to treat various neurological and neuropsychiatric conditions involving the hippocampus. Continued exploration may lead to the development of more effective, individualized treatment protocols that could significantly impact patient care.
Verbatim Quotes
- “The idea of manipulating neural activity in the hippocampus to help treat these types of conditions is appealing, but because the hippocampus lies so deep inside the brain, the challenge is how to engage these brain cells without using invasive implants or drugs that are not precisely targeted.” — Jing Jiang, UI Assistant Professor of Pediatrics
- “This connectivity-informed strategy provides more precise targeting and modulation, which improves the effectiveness of stimulation effect, and may even help predict individual responses.” — Jing Jiang, UI Assistant Professor of Psychiatry and a member of the Iowa Neuroscience Institute.
